🩸Today's question! See the answer and explanation on the next slide.
#ShwachmanDiamondSyndrome #SDS #InheritedBoneMarrowFailure #Hematology #HCT #StemCellTransplant #Monosomy7 #BMF #PediatricHematology #HEMEHUB
#ShwachmanDiamondSyndrome #SDS #InheritedBoneMarrowFailure #Hematology #HCT #StemCellTransplant #Monosomy7 #BMF #PediatricHematology #HEMEHUB
January 21, 2026 at 1:41 AM
🩸Today's question! See the answer and explanation on the next slide.
#ShwachmanDiamondSyndrome #SDS #InheritedBoneMarrowFailure #Hematology #HCT #StemCellTransplant #Monosomy7 #BMF #PediatricHematology #HEMEHUB
#ShwachmanDiamondSyndrome #SDS #InheritedBoneMarrowFailure #Hematology #HCT #StemCellTransplant #Monosomy7 #BMF #PediatricHematology #HEMEHUB
🧬🩸Today's question! See the answer and explanation on the next slide.
#MECOM #CongenitalThrombocytopenia #BoneMarrowFailure #PediatricHematology #RareGeneticDisorders #IBMFS #RadialAplasia #ClinicalInsights #HemeHub
#MECOM #CongenitalThrombocytopenia #BoneMarrowFailure #PediatricHematology #RareGeneticDisorders #IBMFS #RadialAplasia #ClinicalInsights #HemeHub
January 20, 2026 at 1:07 AM
🧬🩸Today's question! See the answer and explanation on the next slide.
#MECOM #CongenitalThrombocytopenia #BoneMarrowFailure #PediatricHematology #RareGeneticDisorders #IBMFS #RadialAplasia #ClinicalInsights #HemeHub
#MECOM #CongenitalThrombocytopenia #BoneMarrowFailure #PediatricHematology #RareGeneticDisorders #IBMFS #RadialAplasia #ClinicalInsights #HemeHub
💡 Today's question! See the answer and explanation on the next slide.
#DiamondBlackfanAnemia #BoneMarrowFailure #Hematology #eADA #PediatricHematology #HEMEHUB #ClinicalInsights #RareDiseases
#DiamondBlackfanAnemia #BoneMarrowFailure #Hematology #eADA #PediatricHematology #HEMEHUB #ClinicalInsights #RareDiseases
January 12, 2026 at 7:59 PM
💡 Today's question! See the answer and explanation on the next slide.
#DiamondBlackfanAnemia #BoneMarrowFailure #Hematology #eADA #PediatricHematology #HEMEHUB #ClinicalInsights #RareDiseases
#DiamondBlackfanAnemia #BoneMarrowFailure #Hematology #eADA #PediatricHematology #HEMEHUB #ClinicalInsights #RareDiseases
The @fda.gov has expanded the approval of Accrufer® (ferric maltol) to include treatment of pediatric patients aged 10 years and older with #ironDeficiency. Previously the treatment had only been approved for adults.
https://bit.ly/4bkTrDm
#PediatricHematology
https://bit.ly/4bkTrDm
#PediatricHematology
Accrufer Approved for Iron Deficiency in Patients Aged 10 Years and Older
FDA expands Accrufer approval to treat iron deficiency in pediatric patients aged 10 years and older based on phase 3 FORTIS trial outcomes.
bit.ly
January 8, 2026 at 8:52 PM
The @fda.gov has expanded the approval of Accrufer® (ferric maltol) to include treatment of pediatric patients aged 10 years and older with #ironDeficiency. Previously the treatment had only been approved for adults.
https://bit.ly/4bkTrDm
#PediatricHematology
https://bit.ly/4bkTrDm
#PediatricHematology
The @fda.gov has expanded the approval of Thrombate III® to include the treatment of pediatric patients with hereditary #antithrombinDeficiency, in addition to adults. From @medicalprofref.bsky.social.
https://bit.ly/3LQihAD
#PediatricHematology
https://bit.ly/3LQihAD
#PediatricHematology
Thrombate III Approved for Hereditary Antithrombin Deficiency in Children
The FDA has expanded the approval of Thrombate III to include pediatric patients with hATd to treat and prevent thromboembolism.
bit.ly
December 1, 2025 at 5:46 PM
The @fda.gov has expanded the approval of Thrombate III® to include the treatment of pediatric patients with hereditary #antithrombinDeficiency, in addition to adults. From @medicalprofref.bsky.social.
https://bit.ly/3LQihAD
#PediatricHematology
https://bit.ly/3LQihAD
#PediatricHematology
Recent epidemiologic evidence suggest that the incidence of hospital-acquired venous thromboembolism among children in the United States has continued to rise over the past 20 years. buff.ly/Cfcvvv3 #hemesky #HowITreat #pediatrichematology
May 27, 2025 at 3:04 PM
Recent epidemiologic evidence suggest that the incidence of hospital-acquired venous thromboembolism among children in the United States has continued to rise over the past 20 years. buff.ly/Cfcvvv3 #hemesky #HowITreat #pediatrichematology
Treatment intensification in patients with B-ALL with MRD ≥1% at day 19 of remission induction significantly enhances EFS. buff.ly/rp5AL7u #hemesky #lymphoidneoplasia #pediatrichematology
April 27, 2025 at 7:01 PM
Treatment intensification in patients with B-ALL with MRD ≥1% at day 19 of remission induction significantly enhances EFS. buff.ly/rp5AL7u #hemesky #lymphoidneoplasia #pediatrichematology
Treatment intensification in patients with B-ALL with MRD ≥1% at day 19 of remission induction significantly enhances EFS. buff.ly/PFCF4VV #hemesky #lymphoidneoplasia #pediatrichematology
April 25, 2025 at 7:01 PM
Treatment intensification in patients with B-ALL with MRD ≥1% at day 19 of remission induction significantly enhances EFS. buff.ly/PFCF4VV #hemesky #lymphoidneoplasia #pediatrichematology
December 1, 2024 at 9:34 AM